Diseases & Disorders
(G300)
IRS Verified
DX Registered
LEUKEMIA & LYMPHOMA SOCIETY INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$378.3M
Total Revenue
$386.1M
Total Expenses
$372.6M
Net Assets
1181
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
71.8%
Fundraising Efficiency
0.0%
Operating Reserve
11.58x
Liability-to-Asset
42.1%
Revenue Diversification
94.5%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $378.3M | $386.1M | $372.6M | 71.8% | 1181 |
| 2022 | $427.0M | $518.6M | N/A | — | 1177 |
| 2021 | $477.7M | $359.8M | N/A | — | 1300 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.